Management of Hepatitis C Infection with Direct Action Antiviral Drugs (DAA)**

• Κύριοι συγγραφείς: Roberto Focaccia (Συγγραφέας), Rodolfo Ferreira de Mello (Συγγραφέας), Patrícia Silva Montes (Συγγραφέας), Flávio Martin Conti (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Archives of Hepatitis Research - Peertechz Publications, 2015-12-30.
• Θέματα: Review Article
• Διαθέσιμο Online: Connect to this object online.

<p>Several new direct action antiviral drugs (DAA) against the HCV virus (HCV) are approved and marketed. The combination of DAA with pegylated interferon and ribavirin (PR) is only recommended to patients with tolerance to interferon (IFN). IFN-free treatments are now considered elective drug...